Literature DB >> 7019624

Formation of mononuclear phagocyte (macrophage) colonies by mouse spleen cells in liquid culture. II. Its inhibition by the capsular polysaccharide of Klebsiella pneumoniae.

T Yokochi, I Nakashima, M Ohta, T Hasegawa, Y Fujii, N Kato.   

Abstract

The effect of the capsular polysaccharide of Klebsiella pneumoniae type 1 Kasuya strain (CPS-K) on the formation of macrophage colonies in cultures of mouse spleen cells was investigated by the liquid culture technique during an incubation period of 7-8 days. CPS-K markedly inhibited further generation of macrophage colonies when added at any time after the beginning of culture, whereas it showed no destructive effect on macrophage colonies which were already formed before its addition. When CPS-K was present throughout the incubation period, such a low concentration as 0.05 micrograms/ml significantly inhibited colony formation, and the intensity of its inhibitory effect depended on its dose in the range of 0.005-50 micrograms/ml. The inhibitory effect persisted even if CPS-K was washed out after spleen cells were kept in contact with 20 micrograms of CPS-K per ml at 37 C for 6 hr. It was found that the inhibitory effect of CPS-K on colony formation was not mediated through its action on T cells, B cells or macrophages, and that it was not due to the generation of suppressor cells capable of inhibiting colony formation. It is concluded therefore that CPS-K directly inhibits the proliferation of macrophage colony-forming cells. The active substance responsible for the inhibitory effect of CPS-K on colony formation is the neutral polysaccharide fraction of CPS-K.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7019624     DOI: 10.1111/j.1348-0421.1981.tb00004.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  1 in total

1.  In vivo effects of bacterial lipopolysaccharide on proliferation of macrophage colony-forming cells in bone marrow and peripheral lymphoid tissues.

Authors:  T Yokochi; I Nakashima; N Kato; T Miyadai; K Yoshida; Y Kimura
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.